Cargando…
COVID-19 and antiphospholipid antibodies
Antiphospholipid syndrome and the coagulopathy of COVID-19 share many pathophysiologic features, including endotheliopathy, hypercoagulability, and activation of platelets, complement pathways, and neutrophil extracellular traps, all acting in concert via a model of immunothrombosis. Antiphospholipi...
Autores principales: | Butt, Ayesha, Erkan, Doruk, Lee, Alfred Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568270/ https://www.ncbi.nlm.nih.gov/pubmed/36494152 http://dx.doi.org/10.1016/j.beha.2022.101402 |
Ejemplares similares
-
The ABCs of antiphospholipid syndrome
por: Bahar Keleşoğlu Dinçer, Ayşe, et al.
Publicado: (2023) -
P1637: PROTEOMIC PROFILING OF DIFFERENT ANTIPHOSPHOLIPID ANTIBODY-POSITIVE PHENOTYPES: RESULTS FROM ANTIPHOSPHOLIPID SYNDROME ALLIANCE FOR CLINICAL TRIALS AND INTERNATIONAL NETWORKING (APS ACTION) REGISTRY
por: Butt, Ayesha, et al.
Publicado: (2023) -
The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome
por: Erkan, Doruk, et al.
Publicado: (2016) -
Incidence of Antiphospholipid Syndrome: Is Estimation Currently Possible?
por: Ioannou, Yiannis, et al.
Publicado: (2023) -
Clinical Insights into Diffuse Alveolar Hemorrhage in Antiphospholipid Syndrome
por: Stoots, Sarah Abramson, et al.
Publicado: (2019)